Blue Fin Capital Lowers stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Blue Fin Capital reduced its stake in CVS Health Corp by 13.56% during the most recent quarter end. The investment management company now holds a total of 23,100 shares of CVS Health Corp which is valued at $2,361,744 after selling 3,625 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Apr 14, 2016.CVS Health Corp makes up approximately 1.99% of Blue Fin Capital’s portfolio.

CVS Health Corp opened for trading at $102.2 and hit $103.225 on the upside on Monday, eventually ending the session at $102.5, with a gain of 0.25% or 0.26 points. The heightened volatility saw the trading volume jump to 31,77,972 shares. Company has a market cap of $112,595 M.

Other Hedge Funds, Including , Skylands Capital reduced its stake in CVS by selling 1,500 shares or 9.15% in the most recent quarter. The Hedge Fund company now holds 14,900 shares of CVS which is valued at $1,523,376. CVS Health Corp makes up approx 0.24% of Skylands Capital’s portfolio. Naples Global Advisors added CVS to its portfolio by purchasing 2,807 company shares during the most recent quarter which is valued at $286,988. CVS Health Corp makes up approx 0.12% of Naples Global Advisors’s portfolio.E&g Advisors Lp boosted its stake in CVS in the latest quarter, The investment management firm added 1,070 additional shares and now holds a total of 11,170 shares of CVS Health Corp which is valued at $1,142,021. CVS Health Corp makes up approx 0.74% of E&g Advisors Lp’s portfolio.Endurance Wealth Management boosted its stake in CVS in the latest quarter, The investment management firm added 932 additional shares and now holds a total of 96,772 shares of CVS Health Corp which is valued at $9,893,969. CVS Health Corp makes up approx 1.91% of Endurance Wealth Management’s portfolio. Contravisory Investment Management sold out all of its stake in CVS during the most recent quarter. The investment firm sold 110,792 shares of CVS which is valued $11,327,374.

On the company’s financial health, CVS Health Corp reported $1.53 EPS for the quarter, based on the information available during the earnings call on Feb 9, 2016. Analyst had a consensus estimate of $1.53. The company had revenue of $41145.00 million for the quarter, compared to analysts expectations of $41126.27 million. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 EPS.

Investors should note that on Mar 2, 2016, CVS Health Corp announced a cash dividend of $0.4250. The company’s management has announced Apr 20, 2016 as the ex-dividend date and fixed the record date on Apr 22, 2016. The payable date has been fixed on May 2, 2016.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Shares were Reiterated by Mizuho on Feb 10, 2016 to “Buy” and Lowered the Price Target to $ 104 from a previous price target of $113 .CVS Health Corp was Initiated by Atlantic Equities to “Overweight” on Feb 3, 2016.

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Leave a Reply

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.